Mologen To Pursue Combinations Only After Lefitolimod’s Solo IMPALA Failure

 
• By Sten Stovall
  
Dart
Mologen ends monotherapy approach for lefitolimod after Phase III failure • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D